PMID- 23527250 OWN - NLM STAT- MEDLINE DCOM- 20130917 LR - 20240308 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 3 DP - 2013 TI - AMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice. PG - e59682 LID - 10.1371/journal.pone.0059682 [doi] LID - e59682 AB - Caloric restriction (CR) is a robust dietary intervention known to enhance cardiovascular health. AMP activated protein kinase (AMPK) has been suggested to mediate the cardioprotective effects of CR. However, this hypothesis remains to be tested by using definitive loss-of-function animal models. In the present study, we subjected AMPKalpha2 knockout (KO) mice and their wild type (WT) littermates to a CR regimen that reduces caloric intake by 20%-40% for 4 weeks. CR decreased body weight, heart weight and serum levels of insulin in both WT and KO mice to the same degree, indicating the effectiveness of the CR protocol. CR activated cardiac AMPK signaling in WT mice, but not in AMPKalpha2 KO mice. Correspondingly, AMPKalpha2 KO mice had markedly reduced cardiac function during CR as determined by echocardiography and hemodynamic measurements. The compromised cardiac function was associated with increased markers of oxidative stress, endoplasmic reticulum stress and myocyte apoptosis. Mechanistically, CR down-regulated the expression of ATP5g2, a subunit of mitochondrial ATP synthase, and reduced ATP content in AMPKalpha2 KO hearts, but not in WT hearts. In addition, CR accelerated cardiac autophagic flux in WT mice, but failed to do so in AMPKalpha2 KO mice. These results demonstrated that without AMPK, CR triggers adverse effects that can lead to cardiac dysfunction, suggesting that AMPK signaling pathway is indispensible for energy homeostasis and myocardial adaptation to CR, a dietary intervention that normally produces beneficial cardiac effects. FAU - Chen, Kai AU - Chen K AD - Cardiovascular Health Research Center, Sanford Research, University of South Dakota, Sioux Falls, South Dakota, United States of America. FAU - Kobayashi, Satoru AU - Kobayashi S FAU - Xu, Xianmin AU - Xu X FAU - Viollet, Benoit AU - Viollet B FAU - Liang, Qiangrong AU - Liang Q LA - eng GR - P20 GM103455/GM/NIGMS NIH HHS/United States GR - P20 RR017662/RR/NCRR NIH HHS/United States GR - 8 P20 GM103455-10/GM/NIGMS NIH HHS/United States GR - 5P20RR017662-10/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130319 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Insulin) RN - 0 (Triglycerides) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) SB - IM MH - AMP-Activated Protein Kinases/genetics/*metabolism MH - Adenosine Triphosphate/metabolism MH - Animals MH - Blotting, Western MH - Body Weight MH - *Caloric Restriction MH - Endoplasmic Reticulum Stress/physiology MH - Heart/*growth & development MH - Heart Function Tests MH - Homeostasis/*physiology MH - In Situ Nick-End Labeling MH - Insulin/blood MH - Insulin-Like Growth Factor I/metabolism MH - Mice MH - Mice, Knockout MH - Myocardium/*metabolism MH - Organ Size MH - Oxidative Stress/physiology MH - Signal Transduction/*physiology MH - Triglycerides/blood PMC - PMC3602170 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/03/26 06:00 MHDA- 2013/09/18 06:00 PMCR- 2013/03/19 CRDT- 2013/03/26 06:00 PHST- 2012/12/20 00:00 [received] PHST- 2013/02/16 00:00 [accepted] PHST- 2013/03/26 06:00 [entrez] PHST- 2013/03/26 06:00 [pubmed] PHST- 2013/09/18 06:00 [medline] PHST- 2013/03/19 00:00 [pmc-release] AID - PONE-D-12-40479 [pii] AID - 10.1371/journal.pone.0059682 [doi] PST - ppublish SO - PLoS One. 2013;8(3):e59682. doi: 10.1371/journal.pone.0059682. Epub 2013 Mar 19.